The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Lifetime Incidence of CKD Stages 3-5 in the United States
Open accessAbstract
Background Lifetime risk estimates of chronic kidney disease (CKD) can motivate preventative behaviors at the individual level and forecast disease burden and health care utilization at the population level. Study Design Markov Monte Carlo model simulation study. Setting & Population Current U.S. black and white population. Model, Perspective, & Timeframe Markov models simulating kidney disease development, using an individual perspective and lifetime horizon. Outcomes Age-, sex- and race-specific residual lifetime risks of CKD stages 3a+ (eGFR<60 ml/min/1.73m2), 3b+ (eGFR<45 ml/min/1.73 m2), and 4+ (eGFR<30 ml/min/1.73m2), and end stage renal disease (ESRD). Measurements State transition probabilities of developing CKD and of dying prior to its development were modeled using: 1) mortality rates from National Vital Statistics Report, 2) mortality risk estimates from a 2-million person meta-analysis, and 3) CKD prevalence from National Health and Nutrition Examination Surveys. Incidence, prevalence, and mortality related to ESRD were supplied by the US Renal Disease System. Results At birth, the overall lifetime risks of CKD stages 3a+, 3b+, 4+, and ESRD were 59.1%, 33.6%, 11.5%, and 3.6%, respectively. Women experienced greater CKD risk yet lower ESRD risk than men; blacks of both sexes had markedly higher CKD stage 4+ and ESRD risk (lifetime risks for white men, white women, black men, and black women, respectively: 53.6%, 64.9%, 51.8%, and 63.6% [CKD stage 3a+]; 29.0%, 36.7%, 33.7%, and 40.2% [CKD stage 3b+]; 9.3%, 11.4%, 15.8%, and 18.5% [CKD stage 4+]; and 3.3%, 2.2%, 8.5%, and 7.8% [ESRD]). Risk of CKD increased with age, with approximately one-half of CKD stage 3a+ cases developing after 70 years of age. Limitations CKD incidence estimates were modeled from prevalence in the U.S. population. Conclusions In the U.S., the lifetime risk of developing CKD stage 3a+ is high, underscoring the importance of primary prevention and effective therapy to reduce CKD-related morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationAhmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Self-citationLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Epidemiology: Beyond the Basics
Szklo, M., & Nieto, F. J. (1999) · Cited by 1,441
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Self-citationVasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., D'Agostino, R. B., & Levy, D. (2002) · JAMA · doi:10.1001/jama.287.8.1003 · Cited by 1,388
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241 · cited 1×
“Older adults experience a dramatically greater incidence of kidney disease than do younger adults.(20,21) Blacks face a greater risk of”
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
Lifetime risk of developing coronary heart disease
Lloyd-Jones, D. M., Larson, M. G., Beiser, A., & Levy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10279-9 · Cited by 929
Glover, J. W. (2010) · Cited by 917
Gansevoort, R. T., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.531 · Cited by 883
Self-citationUS Renal Data System 2011 Annual Data Report
Collins, A. J., Foley, R. N., Chavers, B., Gilbertson, D., Herzog, C., Johansen, K., Kasiske, B., Kutner, N., Liu, J., St. Peter, W., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.015 · Cited by 820
United States Life Tables, 2017.
Arias, E., & Xu, J. (2019) · PubMed · Cited by 804
Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
on behalf of the Family Investigation of Nephropathy and Diabetes (FIND) Research Group, Kao, W. H. L., Klag, M. J., Meoni, L. A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.232 · Cited by 649
Self-citationAge and Association of Kidney Measures With Mortality and End-stage Renal Disease
Hallan, S. I., Matsushita, K., Sang, Y., Mahmoodi, B. K., Black, C., Ishani, A., Kleefstra, N., Naimark, D., Roderick, P., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.16817 · Cited by 636
Self-citationA population-based study of the incidence and outcomes of diagnosed chronic kidney disease
Drey, N., Roderick, P., Mullee, M., & Rogerson, M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00916-8 · Cited by 354
James, M. T., Hemmelgarn, B. R., Wiebe, N., Pannu, N., Manns, B. J., Klarenbach, S. W., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61271-8 · Cited by 353
Patient Awareness of Chronic Kidney Disease: Trends and Predictors
Plantinga, L. C., Boulware, L. E., Coresh, J., Stevens, L. A., Miller, E. R., Saran, R., Messer, K. L., Levey, A. S., & Powe, N. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2268 · Cited by 317
Self-citationEpidemiology: Beyond the Basics
Uzych, L. (2001) · Family & Community Health · doi:10.1097/00003727-200104000-00014 · Cited by 316
Tarver-Carr, M. E., Powe, N. R., Eberhardt, M. S., LaVeist, T. A., Kington, R. S., Coresh, J., & Brancati, F. L. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026493.18542.6a · Cited by 284
Self-citationChronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
Dalrymple, L. S., Katz, R., Kestenbaum, B., Shlipak, M. G., Sarnak, M. J., Stehman-Breen, C., Seliger, S., Siscovick, D., Newman, A. B., & Fried, L. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1511-x · Cited by 262
United States life tables, 2005.
Arias, E., Rostron, B. L., & Tejada‐Vera, B. (2010) · PubMed · Cited by 250
Freedman, B. I., Hicks, P. J., Bostrom, M. A., Cunningham, M. E., Liu, Y., Divers, J., Kopp, J. B., Winkler, C. A., Nelson, G. W., Langefeld, C. D., et al. (2009) · Kidney International · doi:10.1038/ki.2008.701 · Cited by 189
Population based screening for chronic kidney disease: cost effectiveness study
Manns, B., Hemmelgarn, B., Tonelli, M., Au, F., Chiasson, T. C., Dong, J., Klarenbach, S., & on behalf of the Alberta Kidney Disease Network (2010) · BMJ · doi:10.1136/bmj.c5869 · Cited by 161
Rates of Treated and Untreated Kidney Failure in Older vs Younger Adults
Hemmelgarn, B. R., James, M. T., Manns, B., O’Hare, A. M., Muntner, P., Ravani, P., Quinn, R. R., Turin, T. C., Tan, Z., Tonelli, M. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.6455 · Cited by 157
Peralta, C. A., Katz, R., DeBoer, I., Ix, J. H., Sarnak, M. J., Kramer, H., Siscovick, D. S., Shea, S., Szklo, M., & Shlipak, M. G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090960 · Cited by 152
Peralta, C. A., Shlipak, M. G., Fan, D., Tilde]ez, J. O., Lash, J. P., Chertow, G. M., & Go, A. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101122 · Cited by 148
Cumulative Risk for Developing End-Stage Renal Disease in the US Population
KIBERD, B. A., & Clase, C. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014251.87778.01 · Cited by 143
Rate of Kidney Function Decline in Older Adults: A Comparison Using Creatinine and Cystatin C
Shlipak, M. G., Katz, R., Kestenbaum, B. R., Fried, L. F., Newman, A. B., Siscovick, D. S., Stevens, L., & Sarnak, M. J. (2009) · American Journal of Nephrology · doi:10.1159/000212381 · Cited by 142
Genetics of kidney failure and the evolving story of APOL1
Friedman, D. J., & Pollak, M. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46263 · Cited by 140
Chronic kidney disease and life expectancy
Turin, T. C., Tonelli, M. A., Manns, B., Ravani, P., Ahmed, S. B., & Hemmelgarn, B. R. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs052 · Cited by 137
Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC Study
Bash, L. D., Coresh, J., Köttgen, A., Parekh, R. S., Fülöp, T., Wang, Y., & Astor, B. C. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp151 · Cited by 124
Self-citationAssociation of CKD With Disability in the United States
Plantinga, L., Johansen, K. L., Crews, D. C., Shahinian, V. B., Robinson, B. M., Saran, R., Burrows, N. R., Williams, D. E., & Powe, N. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.08.016 · Cited by 111
National Kidney Disease Education Program
Hostetter, T. H., & Lising, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070156.78824.c7 · Cited by 106
Bash, L. D., Astor, B. C., & Coresh, J. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.006 · Cited by 100
Self-citationHoerger, T. J., Wittenborn, J. S., Segel, J. E., Burrows, N. R., Imai, K., Eggers, P. W., Pavkov, M. E., Jordan, R., Hailpern, S. M., Schoolwerth, A. C., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.016 · Cited by 99
Turin, T. C., Tonelli, M. A., Manns, B., Ahmed, S. B., Ravani, P., James, M. T., & Hemmelgarn, B. R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020164 · Cited by 95
Evans, K., Coresh, J., Bash, L., Gary-Webb, T. L., Köttgen, A., Carson, K. A., & Boulware, L. E. (2011) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfq473 · Cited by 95
Self-citationUnited States life tables, 2007.
Arias, E. (2011) · PubMed · Cited by 79
Albuminuria and Racial Disparities in the Risk for ESRD
McClellan, W. M., Warnock, D. G., Judd, S. E., Muntner, P., Kewalramani, R., Cushman, M., McClure, L. A., Newsome, B. B., & Howard, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101085 · Cited by 79
Racial Differences in the Incidence of Chronic Kidney Disease
Muntner, P., Newsome, B., Kramer, H., Peralta, C. A., Kim, Y., Jacobs, D. R., Kiefe, C. I., & Lewis, C. E. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06450611 · Cited by 71
Classification of Chronic Kidney Disease in the Elderly: Pitfalls and Errors
Winearls, C. G., & Glassock, R. J. (2011) · Nephron Clinical Practice · doi:10.1159/000328013 · Cited by 54
Narva, A. S., & Briggs, M. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.038 · Cited by 51
Semba, R. D., Fink, J. C., Sun, K., Cappola, A. R., Dalal, M., Crasto, C., Ferrucci, L., & Fried, L. P. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08070811 · Cited by 38
Long-term risk projection and its application to nephrology research
Turin, T. C., & Hemmelgarn, B. R. (2012) · Journal of Nephrology · doi:10.5301/jn.5000197 · Cited by 10
Cited by
Epidemiology of chronic kidney disease: an update 2022
Kovesdy, C. P. (2022) · Kidney International Supplements · doi:10.1016/j.kisu.2021.11.003 · Cited by 2,973
Chronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Self-citationCoresh, J., Turin, T. C., Matsushita, K., Sang, Y., Ballew, S. H., Appel, L. J., Arima, H., Chadban, S. J., Cirillo, M., Djurdjev, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6634 · Cited by 988
Self-citationRisk of End-Stage Renal Disease Following Live Kidney Donation
Muzaale, A. D., Massie, A. B., Wang, M.-C., Montgomery, R. A., McBride, M. A., Wainright, J. L., & Segev, D. L. (2014) · JAMA · doi:10.1001/jama.2013.285141 · Cited by 982
Self-citationLovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Metadata
- Authors
- Grams, M. E., Chow, E. K. H., Segev, D. L., & Coresh, J.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 62
- Issue
- 2
- Pages
- 245-252
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2096923533
- Cited by
- 302
- References
- 52
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.